Barnett Eva Renee

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$2.88M

Insider Activity of Barnett Eva Renee

According to the SEC Form 4 filings, Barnett Eva Renee, being in a position of

  1. Chief Financial Officer at Immunovant, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 53446 shares for $1.5M,
    over all time since 2022-01-07, has bought 0 shares, and sold 136006 shares for $2.88M.

The largest sale of all time was on 2024-04-17 and amounted to 12253 shares of Immunovant, Inc. for $356,049.

Biography of Barnett Eva Renee

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,502,27212100

Comparison of Insiders on Amount of Buys and Sells

2025-02-19SaleImmunovant, Inc.
IMVT
Chief Financial Officer
2,814
0.0017%
$20.86$58,700-5.73%
2025-01-15SaleImmunovant, Inc.
IMVT
Chief Financial Officer
2,298
0.0016%
$23.83$54,757-16.27%
2025-01-08SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,105
0.0028%
$24.10$98,931-11.98%
2024-11-20SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,174
0.0028%
$25.45$106,228-10.58%
2024-10-16SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,271
0.0023%
$28.79$94,172-14.3%
2024-10-09SaleImmunovant, Inc.
IMVT
Chief Financial Officer
5,162
0.0037%
$29.56$152,589-15.02%
2024-08-21SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,768
0.0025%
$31.86$120,045-13.68%
2024-07-17SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,123
0.0021%
$29.69$92,733-5.9%
2024-07-09SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,747
0.0035%
$28.06$133,201-4.48%
2024-05-22SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,042
0.0028%
$29.65$119,845-5.48%
2024-04-17SaleImmunovant, Inc.
IMVT
Chief Financial Officer
12,253
0.0086%
$29.06$356,049-0.74%
2024-04-09SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,689
0.0025%
$31.18$115,023-9.11%
2024-02-22SaleImmunovant, Inc.
IMVT
Chief Financial Officer
2,930
0.002%
$36.15$105,920-19.81%
2024-01-11SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,515
0.0024%
$41.83$147,023-31.2%
2023-11-22SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,055
0.0028%
$32.78$132,920-7.02%
2023-10-10SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,557
0.0031%
$36.92$168,244-16.11%
2023-08-24SaleImmunovant, Inc.
IMVT
Chief Financial Officer
14,386
0.0111%
$20.30$292,036+57.32%
2023-07-19SaleImmunovant, Inc.
IMVT
Chief Financial Officer
2,725
0.0024%
$24.94$67,962+35%
2023-04-18SaleImmunovant, Inc.
IMVT
Chief Financial Officer
3,423
0.0026%
$15.27$52,269+97.72%
2023-01-11SaleImmunovant, Inc.
IMVT
Chief Financial Officer
4,510
0.0033%
$16.75$75,525+19.33%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD